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IN the present study the human monoblast cell line
U937 has been used as a model to study the function
of  human  mononuclear phagocytes in asthma.  The
kinetics of  the production of  eicosanoids  and  cyto-
kines,  which  are  thought  to  play  a  role  in  the
pathogenesis of asthma, were studied. In addition, the
effects  of  glucocorticosteroids  were investigated,  as
these drugs are of great importance for the treatment
of asthmatic patients. After stimulation with phorbol-
12 myristate acetate (PMA) for 24 h, U937 cells were
cultured  in  the  absence  or  presence  of  lipopoly-
saccharide (LPS: 1 and 5 m g ml–1) and glucocorticoste-
roids  (budesonide,  fluticasone  propionate  and  pre-
dnisolone:  10–11,  10–9 and  10–7 M)  for  96 h.  The
production  of  interleukin-  1b (IL-1b ),  interleukin-6
(IL-6), prostaglandin E2 (PGE2) and thromboxane B2
(TxB2) gradually increased in time after stimulation
with LPS, whereas the transient production of tumor
necrosis factor alpha (TNF-a ) reached its maximum
between 6 and 12 h. Interferon-gamma (IFN-g ), inter-
leukin-10 (IL-10) and leukotriene B4 (LTB4) were not
detectable.  All  three  glucocorticosteroids  (budeso-
nide, fluticasone propionate and prednisolone) com-
pletely inhibited the production of both eicosanoids
and  cytokines.  The  production  of  eicosanoids  was
more  sensitive  to  these  glucocorticoids  than  the
production of cytokines. The observed differences in
the  kinetics  of  the  production  of  eicosanoids  and
cytokines  stress  the  importance  of  time  course
experiments  in  studies  on  the  effect  of  drugs  on
mononuclear cells.
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Introduction
Inflammation of the airways underlies a major part of
the clinical symptoms in asthma and chronic obstruc-
tive pulmonary diseases (COPD). A number of studies
support the involvement of mononuclear phagocytes
in  asthma.1–3 Alveolar  macrophages  phagocytose
inhaled  particles and  antigens,  but  as inflammatory
cells they are known to produce potent inflammatory
mediators,  including  proteins  and  lipids  mediators,
which are able to influence other cell types.
Several features of asthma can be mimicked in vitro
and  in  vivo by  these  secretory  products.4 We  and
others have previously shown that prostaglandin D2,
prostaglandin F2a and a stable analogue of thrombox-
ane A2all constrict human airway muscle.5Leukotriene
B4 (LTB4) increases vascular permeability and enhan-
ces adherence and migration of granulocytes. Inhala-
tion of LTB4 results in peripheral neutropenia and the
accumulation  of  leucocytes  in  the  airway  wall.6
Leukotriene C4 (LTC4) induces bronchoconstriction,
reduces the clearance of mucus and increases vascular
permeability.7Cytokines, such as IL-1b , IL-6 and TNF-a ,
play  an  important  role  in  immune  reactions  and
regulate the growth and state of activity of many cells
in  inflammation  including  the  airway  inflammation
present  in  asthma.8 Both eicosanoids and  cytokines
can also be released from inflammatory cells in culture.
Some  studies  have  investigated  the  regulation  of
cytokines and eicosanoids in macrophage cell lines or
macrophages  stimulated  with  various  inflammatory
agents.9–13
The human monoblastoid U937 tumour cell line is
widely  used  as  a  model  for  the  maturation  of
monocytic  cells.14 U937  is  an  established  human
monoblast cell line derived from the pleural exudate
of  a  patient  with  diffuse  histiocytic  lymphoma.
Maturation  of  U937  can  be  induced  by  incubation
with different agents, including retinoic acid,15 vita-
min D derivatives,16 cytokines17 and phorbol esters.18
Phorbol ester-induced maturation results in cessation
of  proliferation  and  significant  alterations  in  the
morphology of the cells. Under standard conditions,
U937 cells grow in suspension and exhibit a smooth
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form  cell  clusters  and  extend  pseudopodia  upon
phorbol  ester  treatment.18–20 The  morphological
changes  observed  during  this  maturation  process
suggest functional changes of the U937 cells.
We studied the kinetics of the production of several
cytokines,  IL-1b ,  IL-6,  IL-10,  IFN-g and  TNF-a and
eicosanoids PGE2, TxB2 and LTB4 in U937 to clarify
whether mediators are sequentially released by acti-
vated mononuclear cells. These mediators were stud-
ied, because they are thought to be of importance in
the pathogenesis of the airway inflammation in lung
diseases. Furthermore, the effectiveness of glucocorti-
costeroids to suppress the formation of inflammatory
mediators  was  investigated.  We  used  budesonide,
fluticasone  propionate  and  prednisolone,  because
they are the most important drugs currently used in
the treatment of asthma.
Materials and methods
Cell culture
U937 cells (American Type Culture Collection  USA,
batch 1593.2) were cultured in RPMI 1640 medium
(Gibco, UK) supplemented with penicillin (ICN, USA;
100 m g ml–1), streptomycin (ICN, USA; 100 m g ml–1),
glutamax-I (Gibco, UK; 10mM) and 10% foetal bovine
serum  (FBS;  Gibco,  UK)  in  tissue  culture  flasks
(Costar, UK) at 37°C humidified atmosphere with 5%
carbon dioxide.
Maturation of U937 cells was induced with 250ng
ml–1 PMA (Sigma, USA). Cells were cultured for 24h
with  PMA  and  further  grown  for  48h  in  fresh
complete  medium.  Cell  viability  was  assessed  by
trypan-blue exclusion in the non-adherent untreated
U937 as well as in the PMA treated U937 cells. The
viability of the cells was >95%.
The  adherent  cells  were  scraped  from  the  tissue
culture flasks with a rubber policeman and aliquots of
0.5 3 106 cells in 1 ml were put in 24 wells plastic
multiwell culture plates (Costar,  UK) and incubated
with  1 m g  ml–1 or  5 m g  ml–1 or  without  LPS  from
Escherichia coli (Serotype 0111:B4; Sigma, USA). The
cells were incubated for 1, 3, 6, 8, 10, 12, 24, 48 and
96h in separate wells at 37°C. Cell-free supernatants
were  collected  and  stored  at  –80°C  until  measure-
ments of lipid mediators and cytokines.
Incubation with steroids
To ensure that the U937 cell line in our investigations
could be used to evaluate glucocorticoid responsive-
ness, we performed the experiment with steroids. We
used  three  corticosteroids,  namely  budesonide
(Sigma,  USA),  fluticasone  propionate  (gift  of  Glaxo
Wellcome, UK) and prednisolone sodium phosphate
(Genfarma,  NL). The  drugs  were  used  in  the  final
concentrations: 10–11, 10–9 and 10–7 M.
The  cells  were  pre-treated  with  PMA,  the  drugs
were  added  to  the  cell  cultures  24h  prior  to
stimulation with LPS. From this set point [t = 0] the
cells were incubated for 1, 3, 6, 8, 10, 12, 24, 48 and
96h in the presence or absence of the drug and/or
LPS. The cell-free supernatants were stored at –80°C
until measurements.
Cell viability was not altered after drug treatment.
Measurements of cytokines
IL-1b (R&D  systems,  USA),  IL-6  (CLB,  NL),  IL-10
(Pharming, USA), TNF-a (Pharming, USA) and  IFN-g
(Medgenix,  Belgium)  levels  were  measured  using
enzyme- linked immunosorbent assay (ELISA).
Measurements of eicosanoids
The  supernatants  were  processed  as  described  in
detail previously with slight modifications.21 SepPak
C18 cartridges (Waters Ass., USA) were activated with
10ml  of  methanol  pre-washed  with  10ml  distilled
water. Two hundred and fifty m l of supernatant  was
applied  to  the  columns  and  rinsed  with  2.5ml
methanol,  dried  with  a  Savant  Speed-Vac  concen-
trator, and dissolved in 1 ml radioimmunoassay (RIA)
buffer. PGE2 and TxB2 production were measured by
RIA (antibodies were obtained from PerSeptive Diag-
nostics, USA, tritiated antigens from Amersham, UK
and  standards  from  Sigma,  USA).  LTB4 levels  were
measured by enzyme immuno assay (EIA) kits, which
were obtained from Amersham, USA.
Statistical analysis
Each drug was studied in four separate experiments
and  the values are expressed as mean  ± s.e. mean.
Statistical  comparisons  between  control  and  drug-
treated cell cultures were made by ANOVA followed by
paired t-test. A p<0.05 was considered significant.
Results
LPS-induced cytokine production after
pre-treatment with PMA
In standard  medium without PMA, U937 cells had a
smooth and round  surface and  did  not  produce the
cytokines and eicosanoids studied (data not shown).
After  addition  of  PMA  they  became  adherent  by
forming cell clusters, extended pseudopodia and, as
shown  in  Fig.  1,  released  IL-1b ,  IL-6  and TNF-a in
response  to  LPS  stimulation.  However,  LPS  did  not
induce the PMA-treated cells to produce INF-g or IL-10
(data  not  shown).  After  incubation  with  LPS  the
amounts of IL-1b increased significantly at 48 and 96h,
which  seemed  to  be  concentration  dependent.  IL-6
levels  already  increased  significantly  after  6h,  after
which the levels reached a plateau. TNF-a production
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6; its levels increased after 6 h of incubation with LPS,
but started to decrease after 24h.
LPS-induced eicosanoid production after
pre-treatment with PMA
We determined the effects of LPS on PGE2, TxB2 and
LTB4 production by U937 cells which were pre-treated
with PMA. Without PMA, U937 cells did not produce
any of the eicosanoids studied (data not shown). The
cells primed with PMA released PGE2and TxB2, but not
LTB4, in response to LPS (Fig. 2). This effect was time-
related. The levels of TxB2 already reached a plateau
phase after 6 h, whilst the levels of PGE2 increased
slowly with time.
Effect of glucocorticosteroids on the
LPS-induced production of inflammatory
mediators by PMA pre-treated U937 cells
Glucocorticosteroids  downregulate  the  cytokine
expression  of  human  alveolar  macrophages.22 To
investigate whether the U937 cells could be used as
a  model  to  study  glucocorticoid  responsiveness  in
monocytes/macrophages,  we  incubated  the  cells
with  budesonide,  fluticasone  propionate  or  pre-
dnisolone. Figures 3, 4 and 5 show the data obtained
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FIG. 1. Kinetics of IL-1b (top panel), IL-6 (middle panel) and
TNF-a (lower panel) production in PMA-treated U937 cells
which were stimulated with LPS. Data represent mean ± s.e.
mean  obtained  from  four  separate  experiments.  *p<0.05
versus response without LPS. When no error bar is visible,
error falls within the limit of the symbol.
FIG. 2. Kinetics of LTB4 (upper panel), PGE2 (middle panel)
and TxB2 (lower panel) production in PMA-treated U937 cells
which were stimulated with LPS. Data represent mean ± s.e.
mean  obtained  from  four  separate  experiments.  *p<0.05
versus response without LPS. When no error bar is visible,
error falls within the limit of the symbol.with  budesonide,  fluticasone  proprionate  and  pre-
dnisolone respectively. The production  of IL-1b and
IL-6  was  dose-dependently  inhibited  by  all  three
steroids. At  10–7 M concentration, all three steroids
completely abolished the production  of IL- 1b , IL-6
and TNF-a induced by LPS. In the absence of LPS no
production could be found in the supernatant  (data
not shown). Similarly, the production of the eicosa-
noids (PGE2 and TxB2) was already  inhibited by all
three  glucocorticosteroids  at  concentrations  of
10–11M.
Discussion
In  the  present  study  we  have  shown  that  PMA
induced morphological differentiation of U937 cells.
We also found that PMA pre-treated U937 cells needed
LPS for the production of both cytokines (IL-1b , IL-6
and TNF-a and eicosanoids (PGE2 and TxB2). IL-6 was
already detectable after 6 h of incubation, whereas IL-
1b could be detected after 48h. The production  of
both cytokines reached a plateau, in contrast to the
transient  induction  of  TNF-a which  was  maximal
between  6 and  24h. Furthermore, we showed that
the production of eicosanoids could be inhibited by
lower concentrations of glucocorticoids as compared
with the production of cytokines.
Unstimulated  U937 cells  exhibited  a  smooth  and
round  surface, but after PMA addition they became
adherent  by  forming  cell  clusters  and  extended
pseudopodia, which is in agreement with the findings
of Hosoya & Marunouchi.20 Unlike these changes in
morphology, the production of cytokines and eicosa-
noids  could  be  induced  by  LPS  and  PMA  together
only.  However,  Hass  et  al.23 found  that  U937 cells
released IL-1b and TNF-a after TPA treatment without
LPS.  IL-1a and  IL-6  could  not  be  detected  in  their
system. The  basis  of  these  differences  is  unclear. A
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FIG. 3. Effects of budesonide on IL-1b , IL-6, TNF-a , PGE2 and TxB2 production by U937 cells pre-treated and stimulated with
PMA and LPS respectively. Data represent mean ± s.e. mean obtained from four separate experiments. *p<0.05 compared with
control cultures. When no error bar is visible, error falls within the limit of the symbol.possible explanation may be that a subclone of U937
was used different from the one used in our experi-
ments. However, Hass et al.23 also showed in  their
system that TNF-a was expressed earlier (already after
2–4 h) than IL-1b (after 24–48h), and this difference
in kinetics is in agreement with our results.
In this investigation we showed an increase in TNF-
a production until 12h of incubation with LPS. TNF-a
is known  as a  macrophage activator.12 Therefore, it
can  be  expected  that  after  12h  all  the  U937  cells
present in the well would be activated and thus the
production of TNF-a will be terminated. Taimi et al.24
observed that IL-6 is produced by PMA-differentiated
U937 cells after stimulation with LPS. We showed that
the  production  increased  significantly  after  6 h  of
incubation, after which the levels reached a plateau.
This  may  indicate  that  at  this  point  the  cells  have
stopped producing IL-6 and that the amount of IL-6 is
the  actual  amount  that  the  cells  have  produced
without  any  breakdown  of  IL-6. This  plateau  could
also  have  been  reached  because  the  rate  of  break-
down  of  IL-6  equalled  the  production  of  IL-6. We
demonstrated that  the amount  of IL-1b secreted by
PMA pre-treated U937 gradually increased after incu-
bation  with  LPS  even  after  48  and  96h.  Previous
studies have shown that IL-1 generation is dependent
on  the  stage  of  differentiation.25 The  basis  of  the
differential  and  sequential  expression  of  the  three
cytokines studied here may be caused by sequential
secretion  or  gene  expression  during  PMA/LPS-
induced differentiation.
We observed that PMA-treated U937 produced the
eicosanoids  PGE2 and  TxB2,  but  no  LTB4,  after
incubation with LPS. Since LTB4 was not detectable,
the generation of leukotrienes appears to represent a
property of cells at a later state in the differentiation
along  the  monocyte/macrophage  lineage.  K¨ ohler
found that U937 secreted PGE2 and TxB2, but no LTB4
Inflammatory mediators by U937
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FIG. 4.  Effects of  fluticasone propionate on IL-1b ,  IL-6, TNF-a ,  PGE2 and  TxB2 production by U937 cells pre-treated and
stimulated with PMA and LPS respectively. Data represent mean ± s.e. mean obtained from four separate experiments. *p<0.05
compared with control cultures. When no error bar is visible, error falls within the limit of the symbol.after  incubation  with TPA  and  arachidonic  acid  for
1–24h.26 It is known that human peritoneal macro-
phages  do  generate  lipoxygenase  products  after
incubation with Ca-ionophore A23187.13 However, in
this study we found no effect of A23187 (1 and 5 m M
for 15min) on U937 (data not shown).
Previous  studies  have  reported  the  presence  of
glucocorticoid receptors in U937 cells.27 In a recent
study  we  have  demonstrated  under  our  culture
conditions, using the unadapted receptor assay, spe-
cific binding of  3H-labelled dexamethasone to these
cells.  U937 cells  appeared  to  have  17.1 +/–  5.6  3
103 sites per cell and a Kd of 5.3 +/– 1.0nM.28These
findings suggested that U937 cells are glucocorticoid
responsive.  Knudsen  has  demonstrated  that  gluco-
corticosteroids downregulate the IL-1b gene expres-
sion  by  U937,29 which  has  been  confirmed
in  human  alveolar  macrophages  recently.22 In  this
study  we  confirmed  the  glucocorticoid-induced
downregulation of IL-1b in U937 cells, and addition-
ally  we  showed  that  also  the induction  of  IL-6  and
TNF-a is  inhibited  by  different  classes  of  gluco-
corticoids.  Interestingly,  glucocorticoids  were  able
to inhibit the induction of both PGE2 and TxB2 at a
much  lower  concentration  (10–11M)  as  compared
with the inhibition of the cytokines studied (10–7M).
This  difference  may  be  explained by  differences  in
the  underlying  working  mechanism  of  glucocor-
ticoids.  Glucocorticoids  are  thought  to  interfere
with the production of eicosanoids via the induction
of lipocortins. Lipocortin-1 can be induced in differ-
entiated  U937  cells  by  glucocorticoids.30 However,
the downregulation of cytokine expression by gluco-
corticoids is thought to occur at the level of either
transcription  or  translation;  glucocorticoids  may
interact  with  negative  glucocorticoid  response  ele-
ments  in  the  gene of  some  cytokines,  may interact
with other transcription factors or may decrease the
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FIG. 5. Effects of prednisolone on IL-1b , IL-6, TNF-a , PGE2 and TxB2 production by U937 cells pre-treated and stimulated with
PMA and LPS respectively. Data represent mean ± s.e. mean obtained from four separate experiments. *p<0.05 compared with
control cultures. When no error bar is visible, error falls within the limit of the symbol.stability  of  mRNA.31 Future  studies  in  U937 should
focus on the question, which of these three mecha-
nisms, or combination of mechanisms, underlies the
glucocorticoid  effects  on  the  cytokine  expression
observed  here.
In conclusion, the results of this study show that
U937  cells  can  be  used  as  a  model  to  study  the
production  of selected inflammatory  mediators that
are believed to be important  in the pathogenesis of
asthma. Additionally, U937 cells can be used to study
the effects of glucocorticoids on these mediators. The
observed differences in the kinetics of the production
of eicosanoids and cytokines stress the importance of
time course experiments in studies on the effects of
drugs on mononuclear phagocytes.
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